Company intelligence / Profile preview

EBS Technologies

Kleinmachnow, Germany

Ownership: Private
Development stage: Other

Overview

The company has developed a non-invasive medical device technology that leverages the brain's natural ability to repair itself after damage. The therapy is designed to improve deficits in speech, vision, memory, and motor skills in a significantly shorter period and more efficiently than existing training options.

Therapeutic areas: NeurologyOphthalmology
Modalities: Non-pharmacological therapyDevice
Industry: Therapeutic Medical Devices

Beyond the preview

Go deeper on EBS Technologies.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on EBS Technologies.

Explore the full profile